z-logo
open-access-imgOpen Access
Six-month gonadotropin releasing hormone (GnRH) agonist depots provide efficacy, safety, convenience, and comfort
Author(s) -
E. David Crawford
Publication year - 2011
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 40
ISSN - 1179-1322
DOI - 10.2147/cmar.s12700
Subject(s) - leuprorelin , triptorelin , medicine , agonist , prostate cancer , testosterone (patch) , adverse effect , gonadotropin releasing hormone agonist , gonadotropin releasing hormone , oncology , urology , hormone , gynecology , cancer , luteinizing hormone , receptor

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom